Ownership history in Ruffer LLP · 41 quarters on record
This page tracks every 13F SEC filing in which Ruffer LLP reported a position in Pfizer Inc COM (PFE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 1,324,096 | -698,969 | -34.6% | 1.50% | $33.0M | $24.49 |
| 2025 Q3 | ADDED | 2,023,065 | +623,552 | +44.6% | 2.87% | $51.5M | $24.63 |
| 2025 Q2 | REDUCED | 1,399,513 | -792,785 | -36.2% | 1.50% | $33.9M | $23.03 |
| 2025 Q1 | REDUCED | 2,192,298 | -2,014,089 | -47.9% | 2.14% | $55.6M | $23.63 |
| 2024 Q4 | REDUCED | 4,206,387 | -2,319,901 | -35.5% | 4.03% | $111.6M | $24.33 |
| 2024 Q3 | ADDED | 6,526,288 | +797,593 | +13.9% | 5.95% | $188.8M | $26.14 |
| 2024 Q2 | REDUCED | 5,728,695 | -178,963 | -3.0% | 6.88% | $160.3M | $24.92 |
| 2024 Q1 | ADDED | 5,907,658 | +111,646 | +1.9% | 6.31% | $163.8M | $24.35 |
| 2023 Q4 | ADDED | 5,796,012 | +4,133,786 | +248.7% | 6.20% | $166.8M | $24.88 |
| 2023 Q3 | ADDED | 1,662,226 | +489,177 | +41.7% | 2.95% | $53.3M | $28.29 |
As of 2025 Q4 — sorted by position size